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The relationships between the changes of cellular Ca 2+ the activation of phosphoinositide turnover and , 
the functional responses induced by the stimulus-receptor interactions in neutrophils are matter of contro- 
versy. By measuring the concentration dependency of different formyl-leucyl-methionyl-phenylalanine 
(FMLP)-induced changes, the following values of ED,, were found: 1.6 and 0.8 nM for the rise in [Ca2+], 
monitored with Quin-2, in the presence and absence of exogenous Ca2+, respectively; 20 nM for the activa- 
tion of phosphoinositide metabolism, monitored as change in the 32P, of phosphatidate; 14 nM for mem- 
brane-bound Ca2+ mobilization, monitored with chlorotetracycline (CTC); 34 nM for %a2+ influx and 
32 nM for the respiratory burst. Furthermore, low dose of FMLP causes an increase in [Ca”], in absence 
of activation of breakdown of phosphatidylinositol, phosphatidylinositol 4-monophosphate and phospha- 
tidylinositol4,5-biphosphate monitored as changes in [3H]glycerol radioactivity. The results clearly demon- 
strate that the increase in [Ca2+],, due to the release from intracellular stores, is not caused by the breakdown 
of phosphatidylinositides. On the other hand, the data of the similarity of ED,, are compatible with an 
involvement of phosphoinositide response in the release of membrane bound Ca2+, monitored with CTC, 
and in the Wa influx and in the respiratory burst. 
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1. INTRODUCTION 
The functional responses of neutrophils to 
stimulus-receptor interactions are associated with 
an increase in the level of cytosolic Ca*+ concentra- 
tions, [Ca*+]r, due to a change in the plasma mem- 
brane permeability and to a mobilization of in- 
tracellular stores, and with an increase in inositol 
phospholipids metabolism usually called ‘phos- 
phoinositide response’ [l-12]. The coupling of 
these biochemical changes with neutrophil respon- 
ses such as respiratory burst, secretion, aggrega- 
tion, chemotaxis, etc., as well as the nature of the 
reactions involved in the phosphoinositide re- 
sponse, i.e., breakdown of phosphatidylinositol or 
phosphatidylinositoles by phospholipase C or 
phospholipase D type reaction [7,13-161 and their 
relationship with the changes of cellular Ca*+ are 
not yet understood. 
In analogy with other cell types [13,17-201, in 
neutrophils the activation of phosphoinositide 
response would initiate with the breakdown of 
phosphatidylinositol, or of phosphatidylinositol 
4,5-biphosphate, to diacylglycerol and inositol- 
phosphate(s) [lo-12,15,16,21-271. Diacylglycerol 
would then stimulate the Ca*+ and phospholipid 
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dependent protein kinase C [17,19-21,23-251, 
while inositolphosphates would induce the release 
of Ca2+ from intracellular stores and the opening 
of Ca*+ channels in the plasma membrane [13, 
14,18-201. In this view the phosphoinositide re- 
sponse in neutrophils would cause the rise in cyto- 
solic free Ca*+, [Ca*+]i [21,27]. However, accord- 
ing to others the increase in phosphoinositide turn- 
over and the accompanying processes, like the 
phosphatidate formation and the diacylglycerol 
dependent activation of protein kinase C, are con- 
sequences and not causes of the rise in [Ca”], 
[6,7,101. 
In the course of investigations on the mechanism 
responsible for the desensitization, that occurs in 
neutrophils when formyl-methionyl-leucyl-phenyl- 
alanine (FMLP) is presented to the cells during 
some minutes instead of all at once, we have been 
able to show a dissociation between the changes in 
[Ca*+]i and the phosphoinositide response. In fact, 
when the peptide is presented slowly the depressed 
magnitudes of the respiratory burst and of the 
activation of phosphoinositide response are not ac- 
companied by a parallel depression of the 
magnitude of the rise in [Ca*+]i [22]. 
In an attempt to clarify the relationships bet- 
ween the Ca*+ changes and the activation of in- 
ositol phospholipids turnover in neutrophils we 
have investigated several responses (Ca*+ influx, 
Ca’+ mobilization, increase in [Ca*+]i, activation 
of polyphosphoinositides turnover and respiratory 
burst) following the interaction with different 
doses of FMLP. The results presented here 
demonstrate that the change in [Ca*+]i s not the 
consequence of the activation of phosphoinositide 
response and show that the respiratory burst, the 
influx of Ca*+, the mobilization of membrane- 
bound Ca*+, monitored as chlorotetracycline 
fluorescence decrease, and the activation of 
phosphoinositide response are associated events, 
with similar values of EDso for FMLP. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
Quin-2 AM was purchased from Calbiochem- 
Behring (La Jolla, CA); 32P,, [l ,2,3-3H]glycerol 
and 45CaC12 from New England Nuclear; FMLP, 
cytochalasin B, chlorotetracycline, and all 
phospholipids used as standard were purchased 
254 
from Sigma (Taufkirchen). High performance 
TLC plates were from Merck (FRG). 
2.2. Preparation of neutrophils 
Human neutrophils were isolated from venous 
blood and suspended in Hank’s balanced salt solu- 
tion as previously described [28]. 
2.3. Respiratory burst 
The activation of cell respiration by FMLP was 
measured at 37°C with a Clark oxygen electrode as 
previously described [28]. 
2.4. Modification of cytosolic Cd’ 
The changes in [Ca*‘], were monitored with 
Quin-2 loaded cells according to [29] as previously 
described [22]. The amount of Ca*+ released from 
intracellular pool was determined by comparing 
the Ca*+ dependent fluorescence of Quin-2 loaded 
cells treated with 0.1% Triton to the fluorescence 
of a standard solution of Quin-2 free acid added to 
a batch of unloaded cells. The intracellular water 
content of neutrophils was assumed to be 
0.35 p1/106 cells. The amount of Ca2+ released 
from intracellular stores was measured knowing 
the concentration of the intracellular Quin-2 free 
acid and the percentage of saturation of in- 
tracellular Quin 2. 
2.5. Mobilization of bound Cd’ 
The change in fluorescence of chlorotetracycline 
labelled cells was employed to monitor the 
mobilization of membrane-bound Ca*+ as de- 
scribed in [30]. 
2.6. Measurement of calcium influx 
The uptake of 45Ca2C was measured using the 
rapid Millipore filtration technique as described in 
[311. 
2.7. Phosphoinositide response 
The activation of phosphoinositide turnover was 
measured by following the changes in radioactivity 
of phospholipids labelled with 32P, or [3H]glyce- 
rol. The labelling of phospholipids with [3H]gly- 
cerol was performed by incubation of neutrophils 
(70 x 106/ml) at 37°C in modified Hank’s bal- 
anced salt solution containing 0.5 mM CaC12 with 
20 ,&i/ml [3H]glycerol (38.2 Ci/ mmol) for 
90 min. The cells were washed twice and resus- 
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pended in the same buffer containing 0.5 mM 
CaClz to a final concentration 30 x 106/ml. The 
labelling of phospholipids with 32P was performed 
by incubation of neutrophils in a buffered salt 
solution (pH 7.4) containing: 137 mM NaCl, 2.7 
mM KCI, 1 mM MgCl2, 20 mM Hepes, 0.5 mM 
CaC12, 5.6 mM glucose and incubated (70 x 
106/mI) with 20,zWml 32P, for 60 min at 37°C. 
After labelling cells were washed once and re- 
suspended at 30 x 106/ml in the same buffer. 
Labelled neutrophils (1 ml) suspended in ap- 
propriate media were stimulated with different 
doses FMLP at 37°C for the indicated time. The 
lipids of duplicate or triplicate samples were ex- 
tracted by adding 3.75 ml chloroform/methanol 
(2 : I). In experiments where phosphatidylinositol 
4,5-biphosphate and phosphatidylinositol 4-phos- 
phate were to be examined the above solvent was 
replaced by chloroform/methanol/cone. HCl 
(20 : 40 : 1). The phases were split by adding 1.25 ml 
chloroform and 1.25 ml of 2 M KC1 (or distilled 
water when HCl was present) and mixing. The 
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Fig. 1. Time course and magnitude of different responses toFMLP ( 10m7 M) in human eutrophils. (a) 02 consumption 
(2 x 10’ cells/ml); (b) change in cytosolic [Ca2+]i monitored by Quin-2 (5 x lo6 cells/ml); (c) release of membrane- 
bound Ca2+ monitored by changes in CTC fluorescence (5 x IO6 celtslml); id) 4’Ca uptake; (e) change in [3Hlglycerol- 
Iabelled phosphatidic acid (3 x 10’ cells). The value of zero time was 9220 cpm; (f) change in 3ZP-labeiled phosphatidic 
acid (2 x 10’ cells). The value of zero time was 3100 cpm. A11 the responses were measured in the same batch of ceiis 
and the data are of one experiment representative of five. 
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phases were separated by centrifugation and the 
lower phase was collected and dried under 
nitrogen. The phospholipids were separated on 
thin-layer chromatography (TLC) plates using a 
solvent system of methyl acetate/ 1-propanol/chlo- 
reform/methanol/0.25% KC1 (25 : 25 : 25 : 10: 9) 
[32]. The RF values were 0.21 for phosphatidyl- 
choline, 0.37 for phosphatidylserine, 0.43 phos- 
phatidylinositol, 0.48 for phosphatidic acid, and 
0.52 for phosphatidylethanolamine. Triglycerides 
move with the solvent front. The phosphatidylino- 
sitol 4,5-biphosphate (TPI) and phosphatidylino- 
sitol 4-phosphate (DPI) were separated on high 
performance TLC (HPTLC) plates impregnated 
with potassium oxalate (1070) in a solvent system of 
chloroform/acetone/methanol/acetic acid/water 
(40 : 15 : 13 : 12 : 8, v/v) [26]. The RF values for TPI 
and DPI were 0.33 and 0.39, respectively. 
32P-phospholipids were detected by 
autoradiography and 3H-phospholipids stained 
with IZ vapour in presence of carriers. The areas 
corresponding to the individual lipids were scraped 
into vials, eluted by addition of 0.3 ml of methanol 
followed by 4 ml of Instagel Scintillation liquid 
(Packard) and counted. 
3. RESULTS AND DISCUSSION 
Fig. 1 shows the rapidity of onset and magnitude 
of the activation of the respiratory burst (a), of the 
rise in [Ca’+]i monitored as increase in Quin-2 
fluorescence (b), of the mobilization of the 
membrane-bound Ca2+ monitored as decrease in 
chlorotetracycline fluorescence (c), of the influx of 
Ca2+ monitored as increase in cell associated 
45Ca2+ (d) and of the increase in phosphoinositide 
turnover measured as [3H]glycerol (e) and 32Pi (f) 
incorporation into phosphatidate induced by 
100 nM FMLP in human neutrophils. It can be 
seen that the various responses take place very ear- 
ly, the respiratory one being the more delayed. 
Fig.2 reports the dose response curves of the 
FMLP-induced processes presented in fig.1. The 
data clearly show that the rise in [Ca2+]i is elicited 
by very low dose of the peptide both in presence 
(ED50 = 1.7 nM) and absence (EDso = 0.8 nM) of 
exogenous calcium. Similar values of EDso have 
been found by others [33,34]. Fig.2 also shows the 
dose response curve for phosphoinositide response 
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Fig.2. Concentration-dependency of FMLP-induced 02 
consumption (x); change in [Ca’+], in the presence (A), 
and absence of exogenous calcium (A), of changes in 
CTC fluorescence (o), of %a uptake (B) and of 
incorporation of [32P]P, into phosphatidic acid (0) in 
human neutrophils. All the responses were measured in 
the same batch of cells and the data are of one 
experiment representative of five. 
measured as change in the radioactivity of 
phosphatidate. It can be seen that the curve for this 
response is shifted to the right (ED50 = 20 nM) 
when compared with that for the rise in [Ca”] due 
to the release from intracellular stores. An EDSO 
value of 40 nM for FMLP induced breakdown of 
phosphatidylinositol and phosphatidylinositol 
4,5-biphosphate has been found recently by 
Dougherty et al. [12]. 
The dissociation between change of [Ca”], and 
phosphoinositide response, shown also by Volpi et 
al. [34] as increase in radioactivity of phosphati- 
date, is more precisely demonstrated by the results 
of fig.3, which show the effects of two concentra- 
tions of FMLP (2 nM and 100 nM) on intracellular 
Ca2+ mobilization and on turnover of [3H]glyce- 
rol-labelled phosphatidylinositol, phosphatidylino- 
sitol 4-monophosphate, phosphatidylinositol 4,5- 
biphosphate and phosphatidate. At 100 nM con- 
centration FMLP induces either an increase in 
[Ca’+]i and an activation of phosphoinositide turn- 
over, while at 2 nM the peptide causes only the 
changes in [Ca’+]i and not the activation of 
phosphatidylinositide metabolism. 
This finding is a direct demonstration that in 
neutrophils the activation of Ca2+ mobilization 
from intracellular stores induced by FMLP is not 
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Fig.3. The effect of 100 nM (A) and 2 nM FMLP (B) on 
the cytosolic [Ca”], monitored by Quin-2 and on the 
[3H~giycerol-labelled phospholipids in human neutro- 
phils. The vaIues of zero time were: phosphat~dylino- 
sitol, 83 362 cpm (0); phosphatidylinositol 4-phosphate, 
4732 cpm (A); phosphatidylinositol 4,5_biphosphate, 
2120 cpm (0); and phosphatidic acid, 9220 cpm (A). 
The data are of one experiment representative of three. 
caused by the breakdown of phosphatidylinosi- 
tides. It has been suggested that in these cells the 
changes in phosphoinositide metabolism are conse- 
quent on the mobilization of Ca2+ [6,7,10,15,35]. 
Our finding that the increase in [Ca”], induced by 
low dose of FMLP is not accompanied by the ac- 
tivation of phosphoinositide turnover might in- 
dicate that the two events are unrelated. However, 
if the hypothesis that the increase of the cytosolic 
Ca2+ triggers the phosphoinositides turnover is 
correct, a level of /Ca’+Ji, higher than that reached 
in the experiment reported in fig.3, is required. 
Fig.2 also shows the dose response curves for 
other neutrophil responses to FMLP. All are 
shifted on the right when compared with that for 
the rise in [Ca”], and are practically similar to that 
for phosphoinositide response. The EDso values 
are: 14 nM for Ca2+ mobilization monitored as 
chlorotetracycline fluorescence changes, 34 nM 
for 45Ca2’ influx and 32 nM for the respiratory 
burst. 
The different EDso values for the changes in 
[Ca2’], assayed by Quin-2 and chlorotetracycline 
fluorescence clearly confirm that they monitor 
responses of different pools of Ca*+. The release 
from intracellular stores is responsible for the 
rapid rise in cytosolic Ca’+ concentration 
monitored by Quin-2 and the release from plasma 
membrane-bound Cat+ for the decrease in 
fluorescence of chlorotetracycline loaded neutro- 
phils [34,36,38,39]. 
The similarity of EDSO values for the change of 
chlorotetra~ycline fluorescence and phosphoinosi- 
tide metabolism couId indicate that phosphoinosi- 
tide response is causally related with the mobiliza- 
tion of the plasma membrane pool of Ca’+. 
Similar conclusions could be drawn for the re- 
iationship between phosphoinositide response and 
Ca2+ gating, monitored by the increase of 45Ca2+ 
influx, which also have similar EC)50 values for 
FMLP. If this is the case, the same moIecuIar 
modifications of the plasma membrane would 
cause both Ca” mobilization and opening of Ca’* 
gates. It has been postulated that phosphatidylino- 
sitol 4,Sbiphosphate represents the site of plasma 
membrane-bound Ca2+ and evidences have been 
provided that the breakdown of this phospholipid 
causes the release of CaZf from platelet membrane 
[38]. However, the causal reIationship between 
breakdown of phosphoinositides and Ca2+ mobili- 
zation and gating should be further investigated in 
neutrophils since in some experimental conditions 
the hydrolysis of phosphoinositides is not accom- 
panied by Ca ‘+ changes. We have discussed this 
point in [39], where we reported that the break- 
down of polyphosphatidy~inositides caused in 
neutrophils by exogenous phospholipase C is not 
associated with the release of membrane-bound 
Ca’+. 
Also, the dose response curve for the activation 
of the membrane-bound NADPH oxidase is 
similar to those for the other plasma membrane 
events, phosphoinositide turnover and release of 
bound Ca’+. As for their reIationships, it is worth 
pointing out that the onset of the respiratory burst 
is clearly the more delayed. A dependency of the 
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activation of the NADPH oxidase by FMLP on the 
increase of phosphoinositide turnover and on 
mobilization of plasma membrane-bound Ca’+, is 
compatible with the involvement of the Ca2+ and 
phospholipid dependent protein kinase C as a key 
step in the transduction process for the respiratory 
response in neutrophils. 
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